View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, Feb. 25 (HealthDay News) -- Ciprofloxacin-resistant meningitis has appeared in North America, although the bacteria remain susceptible to other antibiotics, according to a report in the Feb. 26 issue of the New England Journal of Medicine.
Henry M. Wu, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues describe three cases of meningococcal disease caused by ciprofloxacin-resistant Neisseria meningitidis in North Dakota and Minnesota in 2007 and 2008.
The investigators found that the N. meningitidis isolates all belonged to serogroup B and were resistant to ciprofloxacin but remained susceptible to several other antibiotics. The ciprofloxacin-resistant isolates represented 9 percent of total confirmed cases reported in these states during that period. Sequencing the gyrA gene, whose encoded protein is a target of ciprofloxacin, identified a threonine-to-isoleucine mutation associated with fluoroquinolone resistance, the researchers report. Further investigation identified an asymptomatic carrier of the resistant strain and an additional resistant isolate from California.
"Ciprofloxacin-resistant N. meningitidis has emerged in North America," Wu and colleagues write. "It is unclear whether the ciprofloxacin resistance reported here represents a sporadic phenomenon or the early stage of wider dissemination."
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top